TOLERAGEN

pharmaceutical preparations for prevention and/or treatment of antibody-mediated diseases; namely, systemic lupus erythematosus; [ Rh hemolytic disease of the newborn; antiphospholipid antibody syndrome; Grave's disease; myasthenia gravis; Hashimoto's thyroiditis; pemphigus; autoimmune hemolytic anemia; autoimmune thrombocytopenia purpura; antibody mediated infertility; Sjogre's syndrome; mixed connective tissue disease; glomerulonephritis and Goodpasture's syndrome ]